Level C· Early human research exploring benefitsProspective StudyPubMed

Donor-matched comparison of chondrogenic progenitors resident in human infrapatellar fat pad, synovium, and periosteum - implications for cartilage repair.

Mantripragada VP., Piuzzi NS., Bova WA., Boehm C., Obuchowski NA., Lefebvre V.

Prospective Study on Osteoarthritis, Cartilage Damage, published in Connect Tissue Res (2019) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Connect Tissue Res (2019)
Country
England
Reported sample size
—
Source database
PubMed
PMID
31020864
DOI
10.1080/03008207.2019.1611795

Abstract (original English)

Purpose : There is a clinical need to better characterize tissue sources being used for stem cell therapies. This study focuses on comparison of cells and connective tissue progenitors (CTPs) derived from native human infrapatellar fatpad (IPFP), synovium (SYN), and periosteum (PERI). Materials and Methods : IPFP, SYN, PERI were harvested from twenty-eight patients undergoing arthroplasty. CTPs were quantitatively characterized using automated colony-forming-unit assay to compare total nucleated cell concentration-[Cell], cells/mg; prevalence-(P CTP ), CTPs/million nucleated cells; CTP concentration-[CTP], CTPs/mg; proliferation and differentiation potential; and correlate outcomes with patient's age and gender. Results : [Cell] did not differ between IPFP, SYN, and PERI. P CTP was influenced by age and gender: patients >60 years, IPFP and SYN had higher P CTP than PERI ( p < 0.001) and females had higher P CTP in IPFP ( p < 0.001) and SYN ( p = 0.001) than PERI. [CTP] was influenced by age: patients <50 years, SYN ( p = 0.0165) and PERI ( p < 0.001) had higher [CTP] than IPFP; patients between 60 and 69 years, SYN ( p < 0.001) had higher [CTP] than PERI; patients >70 years, IPFP ( p = 0.006) had higher [CTP] than PERI. In patients >60 years, proliferation potential of CTPs differed significantly (SYN>IPFP>PERI); however, differentiation potentials were comparable between all t

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Adipose TissueAdultAgedAged, 80 and overCartilageCell- and Tissue-Based TherapyChondrogenesisFemaleHumansMale

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research